PRESS RELEASE
News
-
-
PRESS RELEASE
Icotrokinra Clinical Study Results Demonstrate Its Potential to Shift Treatment Paradigm and Set a New Standard for Treatment in Plaque Psoriasis
Protagonist Therapeutics announces new data on icotrokinra in Phase 3 studies for moderate-to-severe plaque psoriasis. Launching first head-to-head study vs. ustekinumab -
PRESS RELEASE
Rektron Group's Trading Arm - DL Hudson's Non-Bank Lender, Artis Finance, Enters Administration
Rektron Group Inc., a global commodity trading group, addresses the awareness of Artis Finance Ltd. entering administration in the UK. The company's trading arm remains stable with no material impact -
-
-
PRESS RELEASE
EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for 2024 at €205 million (+10% vs. 2023, -7% vs. forecast) and adjusted EBITDA at €66 million (+7% vs. 2023, -17% vs. forecast)
Brockhaus Technologies AG reports preliminary revenue for 2024 of €205 million (+10% vs. 2023) and adjusted EBITDA of €66 million (+7% vs. 2023). Results below forecast due to operational challenges -
-
-
PRESS RELEASE
EQS-Adhoc: Porsche Automobil Holding SE: Group result after tax for the fiscal year 2024 expected to reach approximately minus 20.0 billion euros due to non-cash effective impairments
Porsche SE expects group result after tax for 2024 to be approximately minus 20.0 billion euros due to non-cash impairments. Impairment tests finalized for investments in Volkswagen AG and Porsche AG -
PRESS RELEASE
New to The Street's Client Roadzen (NASDAQ: RDZN) Named to the Fintech40 Index of Global Fintech Leaders by L'Observatoire de la Fintech
Roadzen, Inc. joins L'Observatoire de la Fintech's Fintech40 Index, a benchmark tracking leading fintech companies globally. The AI-driven company focuses on insurance and mobility innovations
